FindTrial
Sign In

ED50 and ED95 of intrathecal isobaric bupivacaine and ropivacaine for caesarean section

ED50 and ED95 of intrathecal isobaric bupivacaine and ropivacaine for caesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010427
Enrollment
Unknown
Registered
2017-01-13
Start date
2017-01-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caesarean section anaesthesia

Interventions

2:bupivacaine
1:ropivacaine

Sponsors

Department of Anesthesiology, West China Second University Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-40 years healthy single pregnancy,height 150-170cm, 37-41 gestational weeks,BMI 20-35kg/m2; 2. ASA I-II, preoperative fasting 8h; 3. receive voluntary CSEA for Cesarean section.

Exclusion criteria

Exclusion criteria: 1. women in labour; 2. undergoing other operation at the same time; 3. allergy to local anesthetics used; 4. taboo for nerve block; 5. exiting the spinal canal anesthesia contraindications; 6. complicated childbirth; 7. number of childbirth experiences etc.

Design outcomes

Primary

MeasureTime frame
anesthesia effects;—

Countries

China

Contacts

Public ContactYunxia Cai

Department of Anesthesiology, West China Second University Hospital, Sichuan University

mengmengzhu-521@163.com+86 15208209756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026